share_log

Analyst Scoreboard: 5 Ratings For Conmed

Benzinga ·  Apr 25 08:01

Ratings for Conmed (NYSE:CNMD) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings22100
Last 30D10000
1M Ago00000
2M Ago00000
3M Ago12100

The 12-month price targets, analyzed by analysts, offer insights with an average target of $109.8, a high estimate of $129.00, and a low estimate of $98.00. A decline of 11.45% from the prior average price target is evident in the current average.

price target chart

Exploring Analyst Ratings: An In-Depth Overview

A comprehensive examination of how...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment